Skip to main content
Log in

Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The immunohistochemical expression of caveolin-1 (cav-1) was evaluated in a series of gastric carcinomas (GC) and in the adjacent normal gastric mucosa. Cav-1 immuno-expression was found in most GC (94%) with a significantly higher amount in the Lauren intestinal type in comparison to the diffuse-type carcinomas. Interestingly, gastric intestinal metaplasia as well as the cells at the base and neck of gastric pits within all fundic mucosal fragments showed an evident cav-1 immuno-staining, suggesting a histogenetic derivation of these lesions from the trans-differentiation of chief cells or from a cryptic progenitor population at the base of fundic glands, as recently hypothesized by other authors. The absence of significant correlations between cav-1 immuno-expression and the other clinico-pathological parameters, such as the stage of disease or the patients overall survival, indicates that the role of cav-1 in GC is neither stage-specific nor related to prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Scherer PE, Lewis RY, Volontè D et al (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337–29346

    Article  PubMed  CAS  Google Scholar 

  2. Anderson RG, Kamen BA, Tothberg KG et al (1992) Potocytosis: sequestration and transport of small molecules by caveolae. Science 255:410–411

    Article  PubMed  CAS  Google Scholar 

  3. Anderson RG (1993) Caveolae: where incoming and outcoming messengers meet. Proc Natl Acad Sci U S A 90:10909–10913

    Article  PubMed  CAS  Google Scholar 

  4. Razani B, Engelman JA, Wang XB et al (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121–38138

    Article  PubMed  CAS  Google Scholar 

  5. Lee H, Volonte D, Galbiati F et al (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 14:1750–1775

    Article  PubMed  CAS  Google Scholar 

  6. Wiechen K, Diatchenko L, Agoulnik A et al (2001) Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159:1635–1643

    PubMed  CAS  Google Scholar 

  7. Wiechen K, Sers C, Agoulnik A et al (2001) Down-regulation of caveolin1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158:833–839

    PubMed  CAS  Google Scholar 

  8. Joo HJ, Oh DK, Kim YS et al (2004) Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 93:291–296

    Article  PubMed  CAS  Google Scholar 

  9. Yang G, Timme TL, Frolov A et al (2005) Combined c-myc and caveolins-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer 103:1186–1194

    Article  PubMed  CAS  Google Scholar 

  10. Barresi V, Cerasoli S, Paioli G et al (2006) Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropathol 112:617–626

    Article  PubMed  CAS  Google Scholar 

  11. Fine SW, Lisanti MP, Galbiati F et al (2001) Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 115:719–724

    Article  PubMed  CAS  Google Scholar 

  12. Kato K, Hida Y, Miyamoto M et al (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929–933

    Article  PubMed  CAS  Google Scholar 

  13. Ando T, Ishiguro H, Kimura M et al (2007) The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 18:601–609

    PubMed  CAS  Google Scholar 

  14. Burgermeister E, Xing X, Röcken C et al (2007) Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 67:8519–8526

    Article  PubMed  CAS  Google Scholar 

  15. Fenoglio-Preiser C, Carneiro F, Correa P et al (2000) Gastric carcinoma. In: Hamilton SR, Aaltonen LA (eds) Tumours of the digestive system. IARC, Lyon, pp 39–52

    Google Scholar 

  16. Lauren T (1965) The two histologic main types of gastric carcinoma. Acta Pathol Microbiol Scand 64:34

    Google Scholar 

  17. Weir EE, Pretlow TG, Pitts A (1974) A more sensitive and specific histochemical peroxidase stain for the localization of cellular antigen by the enzyme–antibody conjugate method. J Histochem Cytochem 22:1135–1140

    PubMed  CAS  Google Scholar 

  18. Barresi V, Grosso M, Barresi G (2008) Immunohistochemical evidence of caveolin-1 expression in human fetal and neonatal striated muscle and absence in the adult’s. Appl Immunohistochem Mol Morphol 16:267–273

    Article  PubMed  CAS  Google Scholar 

  19. Barresi V, Cerasoli S, Tuccari G (2008) Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28:472–478

    Article  PubMed  Google Scholar 

  20. Kato T, Miyamoto M, Kato K et al (2004) Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinomas and squamous cell carcinoma. Cancer Lett 214:121–128

    Article  PubMed  CAS  Google Scholar 

  21. Karayiannakis AJ, Syrigos KN, Chatzigianni E et al (1998) E-cadherin expression as a differentiation marker in gastric cancer. Hepatogastroenterology 45:2437–2442

    PubMed  CAS  Google Scholar 

  22. Galbiati F, Volonte D, Brown AM et al (2000) Caveolin-1 expression inhibits Wnt/betacatenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 275:23368–23377

    Article  PubMed  CAS  Google Scholar 

  23. Uchino S, Noguchi M, Ochiai A et al (1993) p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54:759–764

    Article  PubMed  CAS  Google Scholar 

  24. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735–6740

    PubMed  CAS  Google Scholar 

  25. Syder AJ, Guruge JL, Li Q et al (1999) Helicobacter pylori attaches to NeuAc alpha 2,3Gal beta 1,4 glycoconjugates produced in the stomach of transgenic mice lacking parietal cells. Mol Cell 3:263–274

    Article  PubMed  CAS  Google Scholar 

  26. Nozaki K, Ogawa M, Williams JA et al (2008) A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroeneterology 134:511–522

    Article  CAS  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Barresi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barresi, V., Giuffre’, G., Vitarelli, E. et al. Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. Virchows Arch 453, 571–578 (2008). https://doi.org/10.1007/s00428-008-0681-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-008-0681-y

Keywords

Navigation